CCWM
GNLX icon

Cassaday & Co Wealth Management’s Genelux GNLX Stock Holding History

Cassaday & Co Wealth Management’s Portfolio GNLX Stock Details GNLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,553
Closed -$6.18K – 1356
2026
Q1 		$6.18K Buy
+2,553
New +$6.96K ﹤0.01% 943

Other funds holding GNLX

WDC
Woodward Diversified Capital Bakersfield, California $227M AUM 40.62% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM

Cassaday & Co Wealth Management's GNLX Position: Q2 2026 in Review

Cassaday & Co Wealth Management sold out of Genelux (GNLX) in Q2 2026, closing a stake of 2,553 shares — an estimated $6.18K sold.

Cassaday & Co Wealth Management first reported a position in GNLX in Q1 2026 and held it in 1 quarter. The position peaked at $6.18K in Q1 2026. 72 funds tracked by Wall St. Rank hold GNLX as of Q2 2026.

  • Cassaday & Co Wealth Management reported no remaining Genelux position as of Q2 2026 after selling out during the quarter.
  • Cassaday & Co Wealth Management sold 2,553 Genelux shares in Q2 2026, an estimated $6.18K.
  • Cassaday & Co Wealth Management first reported a position in Genelux in Q1 2026 and held it in 1 quarter.
  • Cassaday & Co Wealth Management's Genelux position peaked at $6.18K in Q1 2026.
  • 72 funds tracked by Wall St. Rank held Genelux as of Q2 2026.

Based on Cassaday & Co Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.